TCT 1422: TAVR in Severe Aortic Regurgitation Secondary to Acquired Aortico-Left Ventricular Fistula
We Recommend
Disclosures
<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Edwards Lifesciences</li></ul>